Literature DB >> 12556251

Assessing need for long-term oxygen therapy: a comparison of conventional evaluation and measures of ambulatory oximetry monitoring.

Kevin M Fussell1, Dereje S Ayo, Paul Branca, Jeffrey T Rogers, Michael Rodriguez, Richard W Light.   

Abstract

BACKGROUND: Appropriate identification of hypoxic patients with chronic obstructive pulmonary disease (COPD) is important because of the demonstrated survival benefit of long-term oxygen therapy (LTOT) and its associated cost. Resting oxygen saturation (measured via pulse oximetry [S(pO2)]) and lowest exercise S(pO2) (during a 6-min walk test) is the standard method of determining LTOT requirements, but that method does not measure the patient's oxygenation during sleep or activities of daily living. We hypothesized that values obtained via the standard method would correlate poorly with values obtained via ambulatory oximetry monitoring.
METHODS: We conducted a prospective, cohort study in an out-patient pulmonary clinic in a tertiary care referral center, with 20 stable COPD patients who were being evaluated for LTOT with conventional evaluation versus 16-24 hours of ambulatory oximetry.
RESULTS: The resting S(pO2) did not correlate well with mean ambulatory S(pO2) (r = 0.64) or the percent of monitored time spent with S(pO2) < 88% (r = 0.49). The lowest exercise S(pO2) also did not predict mean ambulatory S(pO2) (r = 0.39) or the percent of monitored time spent with S(pO2) < 88% (r = 0.32). Conventional evaluation overestimated LTOT requirements with 16 of the 20 patients developing an S(pO2) < 88%, most of them with exercise only (ie, most had normal resting S(pO2)). With ambulatory monitoring, however, only 3 of the 16 patients spent > 10% of the monitored time with S(pO2) < 88%.
CONCLUSION: There was a poor relationship between the conventional oxygenation assessment method and continuous ambulatory oximetry during LTOT screening with COPD patients.

Entities:  

Mesh:

Year:  2003        PMID: 12556251

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  8 in total

1.  The use (or otherwise) of pulse in general practice.

Authors:  Georgia Ingram; Neil Munro
Journal:  Br J Gen Pract       Date:  2005-07       Impact factor: 5.386

2.  Oximetry feedback flow control simulation for oxygen therapy.

Authors:  Mario G Iobbi; Anita K Simonds; Robert J Dickinson
Journal:  J Clin Monit Comput       Date:  2007-01-05       Impact factor: 2.502

3.  Oxygen Desaturation in Daily Life and During a Laboratory-Based Protocol of Activities of Daily Living in COPD: Is There Relationship?

Authors:  Thaís Sant'Anna; Leila Donária; Nidia A Hernandes; Karina C Furlanetto; Décio S Barbosa; Rik Gosselink; Fabio Pitta
Journal:  Lung       Date:  2017-11-13       Impact factor: 2.584

4.  The relationship of the BODE index to oxygen saturation during daily activities in patients with chronic obstructive pulmonary disease.

Authors:  Michael Cutaia; Robin Brehm; Miriam Cohen
Journal:  Lung       Date:  2011-06-24       Impact factor: 2.584

5.  Wearable Finger Pulse Oximetry for Continuous Oxygen Saturation Measurements During Daily Home Routines of Patients With Chronic Obstructive Pulmonary Disease (COPD) Over One Week: Observational Study.

Authors:  Joren Buekers; Jan Theunis; Patrick De Boever; Anouk W Vaes; Maud Koopman; Eefje Vm Janssen; Emiel Fm Wouters; Martijn A Spruit; Jean-Marie Aerts
Journal:  JMIR Mhealth Uhealth       Date:  2019-06-06       Impact factor: 4.773

6.  SaO2 as a predictor of exercise-induced hypoxemia in chronic obstructive pulmonary disease at moderate altitude.

Authors:  Rafael Acero Colmenares; Carlos Ernesto Lombo Moreno
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-29

Review 7.  Respiratory disorders during sleep in chronic obstructive pulmonary disease.

Authors:  Oreste Marrone; Adriana Salvaggio; Giuseppe Insalaco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 8.  Oxygen therapy during exercise training in chronic obstructive pulmonary disease.

Authors:  M L Nonoyama; D Brooks; Y Lacasse; G H Guyatt; R S Goldstein
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.